NL-OMON23000
Recruiting
Not Applicable
DNA damage response in tumours of patients with endometrial cancer
ErasmusMC0 sites50 target enrollmentTBD
ConditionsEndometrial cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Endometrial cancer
- Sponsor
- ErasmusMC
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with all subtypes of endometrial cancer
Exclusion Criteria
- •Patients will be informed upfront that any relevant findings in this study will be reported back to themselves and to their attending physicians. They cannot participate in the study when they do not consent to these criteria.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage.CTRI/2010/091/000015Dr. KH Reeta,Assistant professorDepartment of PharmacologyAIIMS, New Delhi-11002930
Completed
Not Applicable
Study of the anti-tumor effects by oligonucleotides among the patients with primary lung cancerung cancerJPRN-UMIN000017816Yokohama City University30
Active, not recruiting
Not Applicable
Vitamin C as an anti-cancer drugEUCTR2008-008692-33-DKDepartment of Urology, Herlev Hospital
Recruiting
Not Applicable
DNA damage and Nutritional Profile of ApoE4 carriers, the Major Genetic Risk Factor for Alzheimer’s DiseaseNeurological - Alzheimer's diseaseAlzheimer's DiseaseACTRN12612000098831Commonwealth Scientific and Industrial Research Organisation200
Recruiting
Not Applicable
Assessment of DNA damage-repair capacity in systemic lupus erythematosus patients as a potential biomarker of response to cyclophosphamide.ACTRN12620001287921niversity of Auckland17